Additionally, it is reported that the NF-κB signaling pathway was activated in the human prostatic epithelial and stromal cells of BPH patients, thus serving in the maintenance of cell viability and production of drug resistance [27]. The gene discussed is NFKB1; the disease is benign prostatic hyperplasia.